SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): December 6, 2019

 

iQSTEL Inc.

(Exact name of registrant as specified in its charter)

 

Nevada

 

000-55984

 

45-2808620

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(I.R.S. Employer Identification No.)

 

300 Aragon Avenue, Suite 375

Coral Gables, FL 33134

 

33134

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (954) 951-8191

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425) 

 

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

 

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

 

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]


 

 

SECTION 1 - REGISTRANT'S BUSINESS AND OPERATIONS

 

ITEM 1.01 - ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT

 

On December 6, 2019, we entered into a Securities Purchase Agreement (“SPA”) with Labrys Fund, LP, a Delaware limited partnership (“Purchaser”), pursuant to which we issued and sold to the Purchaser a convertible promissory note, executed on December 6, 2019 in the principal amount of $235,000 (the “Note”). We received $211,500 from the investment less the original issue discount.

 

The maturity date for the Note is June 3, 2020 and the Note bears interest at the rate of 12% per annum. All principal and accrued interest on the Note is convertible into shares of our common stock at the election of the Purchaser at any time at a conversion price equal to the lesser of (i) 50% of the lowest trading price during the previous 30 days and ending on the latest trading date prior to the date of the Note, or (ii) a 50% of the lowest trading price for our common stock during the 30 trading day period immediately prior to conversion.

 

We have the right to prepay the Note at any time prior to 180 days following the closing date, which prepayment must include all outstanding principal, accrued and unpaid interest and other amounts as indicated in the Note.

 

The Note contains customary default events which, if triggered and not timely cured, will result in default interest and penalties.

 

The foregoing description of the SPA and the Note, and the transactions contemplated thereby does not purport to be complete and is subject to, and qualified in its entirety by reference to, the full text of the SPA and the Note, which are included in this Current Report as Exhibits 10.1 and 4.1, respectively, and are incorporated herein by reference.

 

If the Note is converted prior to us paying off such notes under the prepayment provisions, it would lead to substantial dilution to our shareholders as a result of the conversion discounted for the Note. There can be no assurance that there will be any funds available to pay of the Note, or if available, on terms that will be acceptable to us or our shareholders. If we fails to obtain such additional financing on a timely basis, Purchaser may convert the Note and sell the underlying shares, which may result in significant dilution to shareholders due to the conversion discount, as well as a significant decrease in our stock price.

 

SECTION 2 - FINANCIAL INFORMATION

 

ITEM 2.03 – CREATION OF A DIRECT FINANCIAL OBLIGATION

 

The information set forth in Items 1.01 is incorporated into this Item 2.03 by reference.

 

SECTION 9 – FINANCIAL STATEMENTS AND EXHIBITS

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

 

Exhibit

No.

 

Description

4.1

 

Note

10.1

 

Securities Purchase Agreement


 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

iQSTEL Inc.

 

/s/ Leandro Iglesias

Leandro Iglesias

Chief Executive Officer

 

Date: December 9, 2019

 

 

IQSTEL NOTE_PAGE_01.JPG  


 

IQSTEL NOTE_PAGE_02.JPG  


 

IQSTEL NOTE_PAGE_03.JPG  


 

IQSTEL NOTE_PAGE_04.JPG  


 

IQSTEL NOTE_PAGE_05.JPG  


 

IQSTEL NOTE_PAGE_06.JPG  


 

IQSTEL NOTE_PAGE_07.JPG  


 

IQSTEL NOTE_PAGE_08.JPG  


 

IQSTEL NOTE_PAGE_09.JPG  


 

IQSTEL NOTE_PAGE_10.JPG  


 

IQSTEL NOTE_PAGE_11.JPG  


 

IQSTEL NOTE_PAGE_12.JPG  


 

IQSTEL NOTE_PAGE_13.JPG  


 

IQSTEL NOTE_PAGE_14.JPG  


 

IQSTEL NOTE_PAGE_15.JPG  


 

IQSTEL NOTE_PAGE_16.JPG  


 

IQSTEL NOTE_PAGE_17.JPG  


 

IQSTEL NOTE_PAGE_18.JPG  


 

IQSTEL NOTE_PAGE_19.JPG  


 

IQSTEL NOTE_PAGE_20.JPG  


 

IQSTEL NOTE_PAGE_21.JPG  


 

IQSTEL NOTE_PAGE_22.JPG  


 

IQSTEL NOTE_PAGE_23.JPG  


 

IQSTEL NOTE_PAGE_24.JPG  


 

IQSTEL NOTE_PAGE_25.JPG  


 

IQSTEL NOTE_PAGE_26.JPG  


 

IQSTEL NOTE_PAGE_27.JPG  


 

IQSTEL NOTE_PAGE_28.JPG  


 

IQSTEL NOTE_PAGE_29.JPG  


 

IQSTEL NOTE_PAGE_30.JPG  


 

IQSTEL NOTE_PAGE_31.JPG  


 

IQSTEL NOTE_PAGE_32.JPG  


 

IQSTEL NOTE_PAGE_33.JPG  

IQSTEL SPA_PAGE_01.JPG  


 

IQSTEL SPA_PAGE_02.JPG  


 

IQSTEL SPA_PAGE_03.JPG  


 

IQSTEL SPA_PAGE_04.JPG  


 

IQSTEL SPA_PAGE_05.JPG  


 

IQSTEL SPA_PAGE_06.JPG  


 

IQSTEL SPA_PAGE_07.JPG  


 

IQSTEL SPA_PAGE_08.JPG  


 

IQSTEL SPA_PAGE_09.JPG  


 

IQSTEL SPA_PAGE_10.JPG  


 

IQSTEL SPA_PAGE_11.JPG  


 

IQSTEL SPA_PAGE_12.JPG  


 

IQSTEL SPA_PAGE_13.JPG  


 

IQSTEL SPA_PAGE_14.JPG  


 

IQSTEL SPA_PAGE_15.JPG  


 

IQSTEL SPA_PAGE_16.JPG  


 

IQSTEL SPA_PAGE_17.JPG  


 

IQSTEL SPA_PAGE_18.JPG  


 

IQSTEL SPA_PAGE_19.JPG  


 

IQSTEL SPA_PAGE_20.JPG  


 

IQSTEL SPA_PAGE_21.JPG  


 

IQSTEL SPA_PAGE_22.JPG  


 

IQSTEL SPA_PAGE_23.JPG  


 

IQSTEL SPA_PAGE_24.JPG  


 

IQSTEL SPA_PAGE_25.JPG  


 

IQSTEL SPA_PAGE_26.JPG  


 

IQSTEL SPA_PAGE_27.JPG  


 

IQSTEL SPA_PAGE_28.JPG  


 

IQSTEL SPA_PAGE_29.JPG